Skip to main content
Clinical Trials/NCT05896358
NCT05896358
Active, not recruiting
Not Applicable

Dietary Treatment for Post Bariatric Weight Regain:Evaluation of the Efficacy of a KD

University of Roma La Sapienza1 site in 1 country30 target enrollmentMarch 1, 2023
ConditionsObesity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
University of Roma La Sapienza
Enrollment
30
Locations
1
Primary Endpoint
weight change
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

Metabolic surgery has, among all obesity treatments, the best long term efficacy, but weight regain (weight regain, WR) or insufficient weight loss (IWL) are relatively common. These are hard to treat, with dietary treatment often failing, and redo surgery being commonly proposed.The ketogenic diet is vastly utilised to obtain weight loss in obesity, but little data is available regarding its application on post bariatric patients. Ad hoc designed studies are needed to confirm the efficacy and safety of a VLCKD in the treatment of WR and IWL. The aim of this study is to test whether the ketogenic diet is a safe and effective treatment in post bariatric weight regain, compared to its application before bariatric surgery.

Detailed Description

Metabolic surgery is, to date, the strategy for the treatment of obesity with the greatest long-term efficacy. However, especially in those lost to surgical and nutritional follow-up, weight regain (weight regain, WR) or insufficient weight loss (IWL) are relatively common. In particular, depending on the type of surgery considered, it has been observed that up to 40% of subjects undergoing surgery report a WR long term, where data on IWL are still insufficient to draw well-defined estimates. WR and IWL are hard to treat, with dietary treatment often failing, and redo surgery being commonly proposed, with increased risk of complications and little effect. The ketogenic diet is one of the pivotal dietary therapies for the treatment of obesity, with excellent evidence in terms of weight loss and improvement in complications of excess weight. Very little data is available regarding its application on post bariatric patients: Correa and colleagues reported in a retrospective case series the efficacy and safety of a very low calorie ketogenic diet (VLCKD) in 11 patients with IWL or WR after gastric bypass, reporting a good safety profile, good tolerability, and an average weight loss of 9 kg in 2 months of therapy. Although promising, the data in the literature are extremely scarce, and therefore ad hoc designed studies are needed to confirm the efficacy and safety of a VLCKD in the treatment of WR and IWL. The objective of this study is to test whether the application of a ketogenic diet is a safe and effective treatment in post bariatric weight regain, compared to its application before bariatric surgery.

Registry
clinicaltrials.gov
Start Date
March 1, 2023
End Date
January 30, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University of Roma La Sapienza
Responsible Party
Principal Investigator
Principal Investigator

Lucio Gnessi

Full professor

University of Roma La Sapienza

Eligibility Criteria

Inclusion Criteria

  • obesity (BMI ≥ 30 Kg/m2)

Exclusion Criteria

  • Type 1 diabetes mellitus
  • Renal failure (GFR\<60)
  • Liver failure (decompensated cirrhosis)
  • Congenital metabolic diseases
  • Pregnancy
  • lactation
  • Major psychiatric disorder
  • Alcoholism
  • drug addiction
  • patients who are not self-sufficient and without adequate family and social support

Outcomes

Primary Outcomes

weight change

Time Frame: at baseline and right after the dietary intervention (8 weeks)

body mass change (kg) within and between groups

Secondary Outcomes

  • waist circumference change(at baseline and right after the dietary intervention (8 weeks))
  • glucose concentration change(at baseline and right after the dietary intervention (8 weeks))
  • insulin concentration change(at baseline and right after the dietary intervention (8 weeks))
  • uric acid concentration change(at baseline and right after the dietary intervention (8 weeks))
  • triglycerides concentration change(at baseline and right after the dietary intervention (8 weeks))
  • muscle mass change(at baseline and right after the dietary intervention (8 weeks))
  • body fat change(at baseline and right after the dietary intervention (8 weeks))
  • cholesterol concentration change(at baseline and right after the dietary intervention (8 weeks))
  • mean blood pressure change(at baseline and right after the dietary intervention (8 weeks))
  • creatinine concentration change(at baseline and right after the dietary intervention (8 weeks))

Study Sites (1)

Loading locations...

Similar Trials